We report a case in which liver cirrhosis was manifested by dysfibrinogenemia before the diagnosis of liver cirrhosis was made. A patient developed gastrointestinal bleeding and hepatic encephalopathy although liver function tests, prothrombin time (PT), activated partial thromboplastin time (aPTT), bleeding time, fibrin (ogen) degradation products (FDP), and platelet counts were normal. However, thrombin time (TT) was prolonged. The gastrointestinal bleeding (GI bleeding) was successfully treated with cryoprecipitate and fresh frozen plasma (FFP). Key Words: Dysfibrinogenemia—Liver disease—Thrombin time.
Lurie B., Creter D.Coagulation studies for severe liver disease detection in a gastroenterology department. Digestion1981;21:244.
4.
Palascak JE, Martinez JEDysfibrinogenemia associated with liver disease. J Clin Invest1977 ;60:89.
5.
. Francis JL , Armstrong DJFibrinogen-bound sialic acid levels in the dysfibrinogenemia of liver disease. Haemostasis1982;11:215.
6.
Green G., Thomson JM, Dymock IW, Poller L.Abnormal fibrin polymerization in liver disease. Br J Haematol1976; 34:427.
7.
Menitove JEPreparation and clinical use of plasma and plasma fractions. In: Williams WJ, Beutler E, Erslev AJ, Lichtman MA, eds. Hematology, 4th ed, New York: Mc-Graw-Hill, 1990:1659.
